Cipla | CIPLA - Assets

Stock Price
1,183.70
Daily Change
-8.70 -0.73%
Monthly
-10.66%
Yearly
-14.52%
Q2 Forecast
1,166.41

Cipla reported INR401.64B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Arca Biopharma USD 488.62M 20.63M Dec/2025
aTyr Pharma USD 515.34M 408.68M Dec/2025
Bio Path USD 690K 56K Sep/2025
Brainstorm Cell Therapeutics USD 1.02M 358K Dec/2025
Capricor Therapeutics USD 355.95M 229.51M Dec/2025
Cara Therapeutics USD 39.02M 4.73M Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Dr.Reddys Laboratories INR 562.9B 20.89B Dec/2025
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
Immunic USD 40.7M 20.72M Sep/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024
UPL INR 913.91B 33.89B Sep/2025